CClinicalTrials.gg
Not yet recruitingNCT07587177Updated May 14, 2026

mHealth Intervention to Prevent Postpartum Depression and Anxiety in Chilean Women (WWWT)

An interventional study of What Were We Thinking (WWWT) mHealth Intervention in Postpartum Depression (PPD) and Postpartum Anxiety, sponsored by Universidad del Desarrollo. Not yet recruiting. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-14.

Sponsored by Universidad del Desarrollo · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
220
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The goal of this clinical trial is to evaluate the effectiveness of a digital psychoeducational intervention, "What Were We Thinking" (WWWT), to prevent the development of postpartum depression and anxiety symptoms in first-time mothers in Chile. The study includes adult women with a healthy, full-term infant younger than two months who are receiving care in primary health centers.

The main questions it aims to answer are:

  • Does participation in the WWWT intervention reduce depressive and anxiety symptoms at 3 months after the end of the intervention compared to usual care?
  • Does participation in the intervention improve maternal self-efficacy, perceived social support, and coparenting relationship quality compared to usual care? Researchers will compare an experimental group receiving the full WWWT intervention with a control group receiving usual care to determine the effectiveness of the intervention.

Participants will:

  • Complete self-report questionnaires assessing depressive symptoms, anxiety symptoms, maternal self-efficacy, perceived social support, and coparenting at baseline and at 3-month follow-up
  • Be randomly assigned to either the intervention group or the control group
  • Receive the WWWT intervention between 4 and 10 weeks postpartum (intervention group), including:

    • Fourteen psychoeducational video modules (3-5 minutes each) delivered via text messaging over 4-5 weeks
    • Individual contact with a trained facilitator through text messaging
    • One virtual group session with other mothers and a facilitator
  • Continue receiving usual care in primary health services (control group) and receive a shortened version of the intervention after the follow-up assessment
Read the detailed description

Postpartum depression and anxiety are common mental health conditions that affect women during the transition to motherhood and have significant consequences for maternal well-being, parenting, and infant development. In Chile, a substantial proportion of women report elevated depressive and anxiety symptoms during the postpartum period. Despite the implementation of universal screening strategies in primary health care, access to mental health treatment remains limited, as many women identified as at risk do not engage in or receive appropriate care. This gap highlights the need for preventive interventions that can be delivered early and at scale.

Preventive psychosocial interventions targeting modifiable risk factors, such as maternal self-efficacy and perceived social support, have shown effectiveness in reducing the risk of developing postpartum mental health difficulties. However, engagement in face-to-face interventions is often low. In this context, digital health (e-mental health) and mobile health (mHealth) interventions offer a promising alternative, particularly in settings with high mobile phone access and limited mental health resources. Guided digital interventions that include human support have demonstrated higher adherence and effectiveness compared to unguided formats.

"What Were We Thinking" (WWWT) is a psychoeducational, preventive intervention originally developed in Australia to reduce the risk of postpartum depression and anxiety among first-time mothers. The intervention targets key modifiable risk factors, including maternal self-efficacy in infant care and the quality of partner support. The program has been culturally adapted for use in Chile and further adapted to an mHealth format to facilitate delivery through mobile phones.

The Chilean mHealth version of WWWT includes three main components: (1) fourteen brief psychoeducational video modules (3-5 minutes each) delivered via text messaging over a period of 4 to 5 weeks, each accompanied by reflective prompts; (2) asynchronous communication with a trained facilitator through text messaging to provide guidance, answer questions, and support engagement; and (3) one virtual group session with other participating mothers led by the facilitator. The intervention is delivered between 4 and 10 weeks postpartum. Facilitators are trained health professionals (e.g., psychologists, midwives, nurses) with knowledge in perinatal mental health, and they are also responsible for referring participants to primary care services when needed.

A previous feasibility study conducted in Chile demonstrated high acceptability and feasibility of the mHealth WWWT intervention, as well as positive perceptions among participants regarding its usefulness for maternal well-being and partner involvement. Preliminary findings suggested that the intervention may be particularly beneficial for women presenting with mild symptoms at baseline, consistent with its preventive focus. However, no significant differences were found between intervention and control groups in overall symptom levels, possibly due to elevated baseline distress during the COVID-19 pandemic. Therefore, further research is needed to evaluate the effectiveness of the intervention under non-crisis conditions and in a larger sample.

The present study is a randomized controlled trial with two parallel arms (intervention and control) designed to evaluate the effectiveness of the WWWT intervention in preventing postpartum depression and anxiety symptoms. Participants are first-time mothers with infants younger than two months receiving care in primary health centers in Chile. After baseline assessment, participants are randomly assigned (1:1) to either the intervention group, which receives the full WWWT program, or the control group, which receives usual care. Follow-up assessments are conducted 3 months after completion of the intervention.

Primary outcomes include depressive and anxiety symptoms. Secondary outcomes include maternal self-efficacy, perceived social support, and coparenting relationship quality. Outcomes are assessed using validated self-report measures administered online at baseline and follow-up.

This study will provide rigorous evidence on the effectiveness of a scalable, culturally adapted digital preventive intervention for postpartum mental health in a Latin American context. Findings may inform the integration of mHealth interventions into primary health care services and contribute to improving maternal mental health and early child development outcomes.

02

Conditions studied

  • Postpartum Depression (PPD)
  • Postpartum Anxiety

Keywords

  • Postpartum depression prevention
  • Postpartum anxiety prevention
  • Perinatal mental health
  • First-time mothers
  • mHealth intervention
  • Randomized controlled trial
  • Chile
  • What Were We Thinking (WWWT)
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • First-time mothers (primiparous women)
  • Aged 18 years or older
  • Having a healthy, full-term infant younger than 2 months of age
  • Receiving prenatal or postnatal care at participating primary health centers in Chile
  • Having access to a mobile phone capable of receiving calls and text messages
  • Able to understand and communicate in Spanish

Exclusion criteria

Exclusion Criteria:

  • Severe symptoms of depression or anxiety at baseline requiring immediate specialized mental health treatment
  • Severe psychosocial problems (e.g., substance abuse, domestic violence, significant cognitive impairment)
  • Infant born preterm or with severe medical conditions (e.g., genetic disorders or serious neonatal complications)
  • Inability to provide informed consent or participate in study procedures due to language or cognitive barriers
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
220 participants (estimated)

Study arms

  • Experimental
    WWWT Intervention

    Participants receive the full "What Were We Thinking" (WWWT) mHealth intervention between 4 and 10 weeks postpartum. The intervention includes 14 psychoeducational video modules delivered via text messaging over 4-5 weeks, asynchronous support from a trained facilitator via text messages, and one virtual group session. Participants also continue receiving usual primary health care.

    Behavioral: What Were We Thinking (WWWT) mHealth Intervention

  • No intervention
    Usual Care

    Participants receive usual care provided by primary health services. They do not receive the WWWT intervention during the study period. After completion of the follow-up assessment, participants are offered a shortened version of the intervention.

Interventions

  • BehavioralWhat Were We Thinking (WWWT) mHealth Intervention

    The "What Were We Thinking" (WWWT) is a psychoeducational, preventive mHealth intervention designed for first-time mothers to reduce the risk of postpartum depression and anxiety. The intervention targets modifiable risk factors, including maternal self-efficacy in infant care and perceived social support. It is delivered between 4 and 10 weeks postpartum and includes three components: (1) fourteen psychoeducational video modules (3-5 minutes each) delivered via text messaging over 4-5 weeks, accompanied by reflective prompts; (2) asynchronous support from a trained facilitator via text messaging; and (3) one virtual group session led by the facilitator. Facilitators are trained health professionals and can refer participants to primary care services when needed.

05

What researchers measure

Primary outcomes

  1. Postpartum depressive symptoms

    Depressive symptoms assessed using the Edinburgh Postnatal Depression Scale (EPDS)

    Time frame: Baseline and 3 months after completion of the intervention

  2. Postpartum anxiety symptoms

    Anxiety symptoms assessed using the Depression, Anxiety and Stress Scales (DASS-21)

    Time frame: Baseline and 3 months after completion of the intervention

Secondary outcomes

  1. Maternal self-efficacy

    Maternal self-efficacy assessed using the Escala de Evaluación Parental (EEP)

    Time frame: Baseline and 3 months after completion of the intervention

  2. Perceived social support

    Perceived social support assessed using the Multidimensional Scale of Perceived Social Support (MSPSS)

    Time frame: Baseline and 3 months after completion of the intervention

  3. Satisfaction with coparenting

    Satisfaction with coparenting assessed using the Escala de Evaluación Parental (EEP)

    Time frame: Baseline and 3 months after completion of the intervention

06

Study locations

No study locations are listed for this record.

07

References and documents

Publications

  • Coo S, Garcia MI, Perez JC, Aldoney D, Olhaberry M, Fernandez O, Alamo N, Franco P, Perez F, Fernandez S, Fisher J, Rowe H. Online Intervention Targeting Postnatal Depression and Anxiety in Chilean First-Time Mothers: Feasibility Trial. J Pediatr Psychol. 2024 Apr 15;49(4):266-278. doi: 10.1093/jpepsy/jsad086. PubMed 38070171 ↗
  • Coo S, Garcia MI, Awad N, Rowe H, Fisher J. Cultural adaptation of an intervention to prevent postnatal depression and anxiety in Chilean new mothers. J Reprod Infant Psychol. 2021 Jul;39(3):276-287. doi: 10.1080/02646838.2019.1705264. Epub 2019 Dec 17. PubMed 31847567 ↗

Individual participant data

Plan to share: Yes — De-identified individual participant data (IPD) will be shared upon reasonable request after publication of the primary study results. Data that may be shared include participant-level outcome data, baseline characteristics, and study-related variables. Identifiable information will be removed to ensure confidentiality. Requests for data access will require approval by the principal investigator and may be subject to a data sharing agreement. Data will be made available for academic research purposes only.

08

Registry details

Key details

Study ID
NCT07587177
Lead sponsor
Universidad del Desarrollo
Collaborators
University of Barcelona
Responsible party
Soledad Coo Calcagni (Associated Professor, Universidad del Desarrollo) — Principal investigator
First posted
May 14, 2026
Start date
May 1, 2026 (estimated)
Primary completion
Aug 31, 2026 (estimated)
Completion
Aug 31, 2026 (estimated)
Last update
May 14, 2026

Study contacts

Soledad Coo, PhD
Contact
scoo@udd.cl
+56 9 9075 3976

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion